Stock TIVC TIVIC HEALTH SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Tivic Health Systems, Inc.

Equities

TIVC

US8887052095

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-25 EDT 		5-day change 1st Jan Change
0.398 USD -2.90% Intraday chart for Tivic Health Systems, Inc. +2.21% -77.89%
06-18 Tivic Health Systems, Inc. Announces Board of Director Changes CI
05-30 Tivic Health Systems, Inc. Enters into Sublease Termination Agreement with Czarnowski Display Service, Inc CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tivic Health: Christina Valauri Appointed to Board of Directors
BU
Tivic Health Systems, Inc. Announces Board of Director Changes
CI
Tivic Health Systems, Inc. Enters into Sublease Termination Agreement with Czarnowski Display Service, Inc
CI
Tivic Health Partners with the Feinstein Institutes to Advance its Patent-pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for use in Clinical Indications
BU
Tivic Health Systems, Inc. Partners with the Feinstein Institutes to Advance its Patent-Pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for Use in Clinical Indications
CI
Earnings Flash (TIVC) TIVIC HEALTH SYSTEMS Reports Q1 Revenue $334,000
MT
Tivic Health Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Tivic Health Systems, Inc., Q1 2024 Earnings Call, May 15, 2024
Tivic Reports First Quarter 2024 Financial Results and Subsequent Events
BU
Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast
BU
Tivic Health Announces Closing of $4.0 Million Public Offering
BU
Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study, Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems
AQ
Tivic Health Announces Pricing of $4.0 Million Public Offering
BU
Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study (VNS); Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems
BU
Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study; Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems
CI
Tivic Reports Fiscal Year 2023 Financial Results
BU
Transcript : Tivic Health Systems, Inc., 2023 Earnings Call, Mar 25, 2024
Tivic Health Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tivic Health to Report 2023 Year-End Financial Results on March 25th Via Conference Call and Webcast
BU
Tivic Health Announces Completion of Enrollment for Study of Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TIVC Stock
  4. News Tivic Health Systems, Inc.